Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
US Stock MarketDetailed Quotes
ProQR Therapeutics (PRQR)
- 1.850
- -0.130-6.57%
Close Apr 10 16:00 ET
- 1.840
- -0.010-0.54%
Post 19:11 ET
194.92MMarket Cap-3.95P/E (TTM)
2.050High1.810Low430.19KVolume2.020Open1.980Prev Close809.62KTurnover0.67%Turnover RatioLossP/E (Static)105.36MShares3.10052wk High3.38P/B118.53MFloat Cap1.08052wk Low--Dividend TTM64.07MShs Float27.600Historical High--Div Yield TTM12.12%Range %0.530Historical Low1.881Avg Price1Lot Size
ProQR Therapeutics (PRQR) Key Financial Indicators
PRQR Earnings per Share (EPS)
According to the latest financial report of ProQR Therapeutics, the latest earnings per share (TTM) for the company is -0.08. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: EUR
Quarterly
Loading...
PRQR Free Cash Flow (FCF)
Interested in knowing about ProQR Therapeutics's free cash flow? The latest report shows it as -13.88M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: EUR
Quarterly
Loading...
PRQR Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of ProQR Therapeutics shows that the company's current ratio is 3.09, indicating healthy liquidity.
Currency: EUR
Quarterly
Loading...
PRQR Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of ProQR Therapeutics, the quick ratio is 3.01, indicating that the company can meet its short-term debt obligations.
Currency: EUR
Quarterly
Loading...
PRQR Return on Equity (ROE)
Want to learn more about the financial health of ProQR Therapeutics? The latest ROE figure is -16.76%, indicating that the company has stable profitability.
Currency: EUR
Quarterly
Loading...
PRQR Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of ProQR Therapeutics, the total asset return on investment (ROA) is -7.52%.
Currency: EUR
Quarterly
Loading...
PRQR Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check ProQR Therapeutics's latest financial report to see how their gross margin is doing - currently at --.
Currency: EUR
Quarterly
Loading...
PRQR Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of ProQR Therapeutics, the net profit margin is -190.27%, which is a good sign for its profitability.
Currency: EUR
Quarterly
Loading...
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
US Vice President Vance stated today that negotiations between the US and Iran have failed to reach an agreement, and the US negotiation del
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm